ES8801831A1 - Un procedimiento para la preparacion de un derivado tetraciclico de espiro-hidantoina biologicamente activo - Google Patents

Un procedimiento para la preparacion de un derivado tetraciclico de espiro-hidantoina biologicamente activo

Info

Publication number
ES8801831A1
ES8801831A1 ES551963A ES551963A ES8801831A1 ES 8801831 A1 ES8801831 A1 ES 8801831A1 ES 551963 A ES551963 A ES 551963A ES 551963 A ES551963 A ES 551963A ES 8801831 A1 ES8801831 A1 ES 8801831A1
Authority
ES
Spain
Prior art keywords
preparation
procedure
biologically active
derivative
tetraciclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES551963A
Other languages
English (en)
Other versions
ES551963A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES8801831A1 publication Critical patent/ES8801831A1/es
Publication of ES551963A0 publication Critical patent/ES551963A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/16—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN DERIVADO TETRACICLICO DE ESPIROHIDANTOINA BIOLOGICAMENTE ACTIVO, DE FORMULA GENERAL (I), Y SUS SALES DE ADICION DE ACIDOS FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN HACER REACCIONAR UN ESTER ETILICO DE FORMULA GENERAL (II), EN LA QUE X ES HIDROGENO, FLUOR, CLORO O METILO; Y R ES -CONH2 O -CONH-CICLOHEXILO, CON UNA AMINA APROPIADA DE FORMULA GENERAL NHR1R2, EN LA QUE R1 Y R2 SON AMBOS HIDROGENO O ETILO. DE APLICACION EN LA PREPARACION DE COMPOSICIONES FARMACEUTICAS APLICABLES EN EL TRATAMIENTO DE LAS COMPLICACIONES DE LA DIABETES.
ES551963A 1984-08-14 1986-02-13 Un procedimiento para la preparacion de un derivado tetraciclico de espiro-hidantoina biologicamente activo Expired ES8801831A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1984/001290 WO1986001107A1 (en) 1984-08-14 1984-08-14 Tetracyclic spiro-hydantoin aldose reductase inhibitors, compositions and methods of making

Publications (2)

Publication Number Publication Date
ES8801831A1 true ES8801831A1 (es) 1988-02-16
ES551963A0 ES551963A0 (es) 1988-02-16

Family

ID=22182231

Family Applications (2)

Application Number Title Priority Date Filing Date
ES546093A Expired ES8704495A1 (es) 1984-08-14 1985-08-12 Un procedimiento para la preparacion de un derivado tetraci-clico de espirohidantoina biologicamente activo.
ES551963A Expired ES8801831A1 (es) 1984-08-14 1986-02-13 Un procedimiento para la preparacion de un derivado tetraciclico de espiro-hidantoina biologicamente activo

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES546093A Expired ES8704495A1 (es) 1984-08-14 1985-08-12 Un procedimiento para la preparacion de un derivado tetraci-clico de espirohidantoina biologicamente activo.

Country Status (24)

Country Link
US (1) US4656169A (es)
EP (1) EP0173497B1 (es)
JP (1) JPS6147486A (es)
KR (1) KR870000624B1 (es)
AT (1) ATE46162T1 (es)
AU (1) AU553699B2 (es)
CA (1) CA1255304A (es)
DD (1) DD236529A5 (es)
DE (1) DE3572818D1 (es)
DK (1) DK366685A (es)
ES (2) ES8704495A1 (es)
FI (1) FI82695C (es)
GR (1) GR851968B (es)
IE (1) IE58123B1 (es)
IL (1) IL76076A0 (es)
IN (2) IN166581B (es)
NO (1) NO164101C (es)
NZ (1) NZ213085A (es)
PH (1) PH22910A (es)
PL (2) PL145221B1 (es)
PT (1) PT80940B (es)
WO (1) WO1986001107A1 (es)
YU (1) YU44894B (es)
ZA (1) ZA856102B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202339A (en) * 1987-08-28 1993-04-13 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
US5004751A (en) * 1987-08-28 1991-04-02 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
FI902028A7 (fi) * 1988-08-24 1990-04-23 Mochida Pharm Co Ltd Hydantoiinijohdannaisia
TW202450B (es) * 1991-06-26 1993-03-21 Dainippon Pharmaceutical Co

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4193996A (en) * 1979-04-04 1980-03-18 Pfizer Inc. Spiro-quinolone hydantoins
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives

Also Published As

Publication number Publication date
ATE46162T1 (de) 1989-09-15
US4656169A (en) 1987-04-07
PT80940A (en) 1985-09-01
KR860001811A (ko) 1986-03-22
KR870000624B1 (ko) 1987-03-26
IN166590B (es) 1990-06-09
ES8704495A1 (es) 1987-04-01
AU553699B2 (en) 1986-07-24
IE851991L (en) 1986-02-14
YU129085A (en) 1988-04-30
PL145221B1 (en) 1988-08-31
IE58123B1 (en) 1993-07-14
EP0173497B1 (en) 1989-09-06
NZ213085A (en) 1988-03-30
NO164101B (no) 1990-05-21
NO164101C (no) 1990-08-29
AU4612685A (en) 1986-02-20
FI861544A7 (fi) 1986-04-11
DD236529A5 (de) 1986-06-11
ES546093A0 (es) 1987-04-01
PH22910A (en) 1989-01-24
PL147875B1 (en) 1989-08-31
PL261413A1 (en) 1988-01-21
PT80940B (pt) 1987-12-30
ES551963A0 (es) 1988-02-16
CA1255304A (en) 1989-06-06
YU44894B (en) 1991-04-30
NO861425L (no) 1986-04-11
PL254960A1 (en) 1987-01-12
FI82695B (fi) 1990-12-31
FI861544A0 (fi) 1986-04-11
JPH0339512B2 (es) 1991-06-14
IN166581B (es) 1990-06-09
DK366685D0 (da) 1985-08-13
IL76076A0 (en) 1985-12-31
JPS6147486A (ja) 1986-03-07
DK366685A (da) 1986-02-15
EP0173497A1 (en) 1986-03-05
WO1986001107A1 (en) 1986-02-27
GR851968B (es) 1985-12-13
ZA856102B (en) 1987-03-25
FI82695C (fi) 1991-04-10
DE3572818D1 (en) 1989-10-12

Similar Documents

Publication Publication Date Title
ES2160640T3 (es) Nuevos (r)-5-carbamoil-8-fluoro-3-amino disustituido en n,n-3,4-dihidro-2h-1-benzopiranos.
ES2157424T3 (es) Esteres de acido 5-aminolevulinico como agentes fotosensibilizantes en fotoquimioterapia.
SE8800731L (sv) Fenylkarbamat
ES2130247T3 (es) Derivados amidino y su uso como inhibidores de la oxido nitrico sintasa.
ES2161290T3 (es) Derivados de quinazolina.
ES2040838T3 (es) Compuestos piperazinil-heterociclicos.
ES2150663T3 (es) Tratamiento de la incontinencia urinaria utilizando (s)-oxibutinina y (s)-desetiloxibutinina.
MD1233B1 (en) Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof
ES2159851T3 (es) Amidas de acidos aminotiofenocarboxilicos y su empleo como inhibidores de la fosfodiestearasa.
MX9307779A (es) Compuestos benzoicos fundidos.
ES469005A1 (es) Un procedimiento para la preparacion de nuevos derivados de somatostatina
ES2143132T3 (es) Monohidratos de derivado de acido aminobenceno-sulfonico y su metodo de preparacion.
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
DK0393493T3 (da) Fluorerede galdesyrederivater, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0648779T3 (da) 11-benzaldoxim-17beta-methoxy-17alfa-methoxymethyl-estradien-derivater, fremgangsmåder til deres fremstilling og lægemidler indeholdende disse forbindelser
AR004688A1 (es) Derivados de la 5-0-desosaminil--6-o-metil-eritronolida a, su procedimiento de preparacion, compuestos intermediarios para su exclusivo uso en dichoprocedimiento para la preparacion de productos biologicamente activo
ES8601942A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
ES2059534T3 (es) Nuevos derivados benzopiranos antihipertensivos.
ES2053668T3 (es) Derivados de poliamina como agentes antineoplasicos.
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
DK0583271T3 (da) Arylmorpholin, fremstilling og anvendelse
NO305163B1 (no) Aminosyrederivater samt terapeutisk middel mot angina pectoris som omfatter et slikt
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
ES470296A1 (es) Mejoras introducidas en un procedimiento para la preparacionde fluormetal-aminoacidos
ES8503676A1 (es) Procedimiento de producir derivados de acido oxazolacetico

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519